Trinity Research Group LLC

1. Allergan Inc. $661,660 106 payments
2. Alcon Research LLC $337,473 623 payments
3. Boehringer Ingelheim Pharmaceuticals, Inc. $114,322 10 payments
4. AbbVie, Inc. $76,579 24 payments
5. Phraxis, Inc. $35,547 2 payments
6. Johnson & Johnson Surgical Vision, Inc. $15,240 6 payments
7. Bard Peripheral Vascular, Inc. $10,000 1 payment
8. Sun Pharmaceutical Industries Inc. $6,405 6 payments
9. Oyster Point Pharma, Inc. $5,642 2 payments
10. Boehringer Ingelheim Finland Ky $4,448 28 payments

1. Post Approval Study of the AcrySof IQ ReSTOR Toric IOL $273,541 520 payments
2. A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension $210,754 25 payments
3. A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension $124,345 16 payments
4. An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension $94,943 20 payments
5. Anti Sema3A for DMI in Treated PDR patients $78,851 6 payments
6. An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension $74,148 13 payments
7. Multicenter Double Masked Randomized Vehicle-Controlled Parallel-Group study of AGN-190584 for Participants with Presbyopia $61,892 6 payments
8. Clinical Evaluation of a Vascular Anastomotic Connector System for Minimally Invasive Connection of a Arteriovenous Graft for Hemodialysis $35,547 2 payments
9. Post Approval Study of the AcrySof IQ ReSTOR Toric IOL (Models SND1T3-T6) $30,839 55 payments
10. PoCP NPDR Study, 1 dose vs placebo, 12 wk $30,412 2 payments

1. Other $36,505 7 payments
2. Patient care $35,547 2 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.